DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

236.12 1.22 (0.52%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $236.12 0.52%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $232.73
Previous Close $234.90
Daily Range $232.04 - $236.36
52-Week Range $111.41 - $263.81
Market Cap $80.9B
P/E Ratio 96.67
Dividend (Yield) $0.00 (0.0%)
Volume 982,983
Average Daily Volume 1,980,756
Current FY EPS $2.96

Sector

Healthcare

Industry

Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

The Berkshire Hathaway of Biotech Strikes Again

Valeant Pharmaceuticals adds to its growing portfolio of products with the purchase of Sprout Pharmaceuticals. Find out what's made Valeant such a great stock to own, and what investors should be monitoring going forward.

Acelity Files To Float, But Is It Secretly Seeking A Buyer?

Sequoia Fund Comments on Valeant Pt. II

Sequoia Fund Comments on Valeant Pt. II

This Week In Pharma: Keryx's Sluggish Drug Launch Vs. Excitement At Valeant And Palatin

Insider Trading Alert - VRX, WSTC And CPHD Traded By Insiders

Sucampo to Acquire R-Tech Ueno for About $278 Million

Sequoia Fund Comments on Valeant Pharmaceuticals

Glenn Greenberg Acquires Two New Stakes

Valeant Pharmaceuticals' (VRX) Charts Read Like a Textbook Bull

Exelixis' Cancer Drug Gets Breakthrough Therapy Status

See More VRX News...

VRX's Top Competitors

VRX $236.12 (0.52%)
Current stock: VRX
JNJ $95.17 (-1.09%)
Current stock: JNJ
NVS $98.35 (-0.29%)
Current stock: NVS
RHHBY $34.16 (-1.98%)
Current stock: RHHBY